Φορτώνει......
The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia
Accumulating evidence suggests that a dysregulation of the glutamatergic system exists in the brains of schizophrenia patients. The metabotropic glutamate (mGlu) receptors are being investigated as novel drug targets for this disease, and have shown promise in both preclinical and clinical studies....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Opin Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5949078/ https://ncbi.nlm.nih.gov/pubmed/29486374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2018.02.003 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|